Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare ConferencePRNewsWire • 02/23/24
Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery DeliveryPRNewsWire • 02/21/24
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer DetectionPRNewsWire • 02/15/24
Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive SurgeryPRNewsWire • 02/13/24
First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.comPRNewsWire • 02/12/24
Quest Diagnostics (DGX) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/01/24
Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per SharePRNewsWire • 02/01/24
Ten Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies"PRNewsWire • 01/31/24
Quest Diagnostics (DGX) Advances in Cancer Research With New DealZacks Investment Research • 01/26/24
Haystack Oncology, developer of Haystack MRD™, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus' TLR9 agonist in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and pancreatic adenocarcinomaPRNewsWire • 01/22/24
Quest Diagnostics to Release Fourth Quarter and Full Year 2023 Financial Results on February 1, 2024PRNewsWire • 01/17/24
Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic HealthPRNewsWire • 01/17/24